Epigenomics AG Statistics

Total Valuation

Epigenomics AG has a market cap or net worth of EUR 754,176. The enterprise value is 11.21 million.

Market Cap	754,176
Enterprise Value	11.21M

Important Dates

The next estimated earnings date is Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Epigenomics AG has 876,949 shares outstanding. The number of shares has increased by 2.76% in one year.

Current Share Class	876,949
Shares Outstanding	876,949
Shares Change (YoY)	+2.76%
Shares Change (QoQ)	+0.41%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	622,084

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.34
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.09

Current Ratio	2.09
Quick Ratio	1.99
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-5.72%
Return on Invested Capital (ROIC)	-6.08%
Return on Capital Employed (ROCE)	-9.93%
Revenue Per Employee	n/a
Profits Per Employee	-1.68M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.78% in the last 52 weeks. The beta is 1.05, so Epigenomics AG's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	+44.78%
50-Day Moving Average	0.86
200-Day Moving Average	1.00
Relative Strength Index (RSI)	60.86
Average Volume (20 Days)	1,821

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.13M
Pretax Income	-3.35M
Net Income	-3.35M
EBITDA	-1.12M
EBIT	-1.13M
Earnings Per Share (EPS)	-3.82

Full Income Statement

Balance Sheet

The company has 927,000 in cash and 11.38 million in debt, giving a net cash position of -10.46 million or -11.92 per share.

Cash & Cash Equivalents	927,000
Total Debt	11.38M
Net Cash	-10.46M
Net Cash Per Share	-11.92
Equity (Book Value)	n/a
Book Value Per Share	n/a
Working Capital	506,001

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.20M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Epigenomics AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.76%
Shareholder Yield	n/a
Earnings Yield	-444.46%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	3